Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors

“The quality of what Pharmacy Management is putting on is simply streets ahead of anything else I’m seeing at the moment. Keep up the good work!”
Noel Wicks, Managing Director, Right Medicine Pharmacy Ltd, Stirling
Satellite Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors
Speakers Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Research, Leeds Teaching Hospitals NHS Trust
Satellite Description

This session has been sponsored, including speaker honoraria and presentation development support, by the Boehringer Ingelheim and Lilly Diabetes Alliance

PC-GB-100225 September 2019

Back to Course

Connect with us Industry NHS

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue